In the latest Thematic Insights report, we look at what companies must do under the Australian drug regulator to bring a new product to market.
CLICK TO DOWNLOAD REPORT
Mesoblast has been featured in the latest Thematic Insights Report - Download now!
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.020(2.04%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.01 | 99.0¢ | $578.1K | 579.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 37539 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 23469 | 8 |
View Market Depth
| Last trade - 10.16am 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |